cold sore fever blister treatment
Generic: docosanol
Labeler: dolgencorp, inc. (dollar general & rexall)Drug Facts
Product Profile
Brand Name
cold sore fever blister treatment
Generic Name
docosanol
Labeler
dolgencorp, inc. (dollar general & rexall)
Dosage Form
CREAM
Routes
Active Ingredients
docosanol 100 mg/g
Manufacturer
Identifiers & Regulatory
Product NDC
55910-859
Product ID
55910-859_996190eb-34cd-4925-abf9-16277bcf41ad
Product Type
HUMAN OTC DRUG
Marketing Category
ANDA
Application Number
ANDA212385
Marketing Start
2023-12-31
Marketing End
2028-02-28
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
55910859
Hyphenated Format
55910-859
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
cold sore fever blister treatment (source: ndc)
Generic Name
docosanol (source: ndc)
Application Number
ANDA212385 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 mg/g
Packaging
- 1 TUBE in 1 PACKAGE (55910-859-07) / 2 g in 1 TUBE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["TOPICAL"], "spl_id": "996190eb-34cd-4925-abf9-16277bcf41ad", "openfda": {"upc": ["0359726922081"], "unii": ["9G1OE216XY"], "rxcui": ["797534"], "spl_set_id": ["5ecf678b-d08a-4082-9d01-4468865a94b2"], "manufacturer_name": ["Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 PACKAGE (55910-859-07) / 2 g in 1 TUBE", "package_ndc": "55910-859-07", "marketing_end_date": "20280228", "marketing_start_date": "20231231"}], "brand_name": "Cold Sore Fever Blister Treatment", "product_id": "55910-859_996190eb-34cd-4925-abf9-16277bcf41ad", "dosage_form": "CREAM", "product_ndc": "55910-859", "generic_name": "Docosanol", "labeler_name": "Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Cold Sore Fever Blister Treatment", "active_ingredients": [{"name": "DOCOSANOL", "strength": "100 mg/g"}], "application_number": "ANDA212385", "marketing_category": "ANDA", "marketing_end_date": "20280228", "marketing_start_date": "20231231"}